Drugmaker Cipla has got regulatory approval to market Afrezza, a rapid acting insulin delivered through an inhaler, as compared to other insulins given through injections. The Central Drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback